Gyulladásos és autoimmun betegségek natalizumabbal való kezelésének módszerei

• 收藏
• 分享

专利权人:

Biogen MA Inc.

发明人:

LIEBERBURG, Ivan

申请号：

HUE13175987

公开号：

HUE047230T2

申请日:

2007.02.28

申请国别(地区):

HU

年份:

2020

代理人:

摘要：

Natalizumab is a safe and efficacious treatment for inflammatory and autoimmune diseases, such as multiple sclerosis, Crohn's Disease, and rheumatoid arthritis. Rare occurrences of progressive multifocal leucoencephalopathy during treatment suggest the possibility that it may be related to natalizumab treatment. Monitoring for JCV and informing caregivers and patients about the manifestations of progressive multifocal leucoencephalopathy can improve the safety of natalizumab therapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/